2 Trademark Results found for "180 LIFE SCIENCES "

Also try searching for:

180 LIFE SCIENCES*

180 *

*CES

18*ES

Mark	Details	Status	Class/Description
	180 LIFE SCIENCES 180 Life Sciences Corp. 2202334 4 Aug 2022	ADVERTISED on 7 May 2025	Analgesic preparations; Pharmaceutical preparations for the treatment ... Class 005 Class 005 Pharmaceutical Products Analgesic preparations; Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the treatment of inflammation; Pharmaceutical preparations for the treatment of Dupuytren's disease; Pharmaceutical preparations for the treatment of frozen shoulder; Pharmaceutical preparations for the treatment of post-operative delirium; Pharmaceutical preparations for the treatment of post-operative cognitive deficit; Pharmaceutical preparations for the treatment of post-operative cognitive decline; Pharmaceutical preparations for the treatment of n on-alcoholic steatohepatitis; Pharmaceutical preparations for the treatment of fibrosis; Pharmaceutical preparations for the treatment of liver fibrosis; Pharmaceutical preparations for the treatment of arthritis; Pharmaceutical preparations for the treatment of pain; Pharmaceutical preparations for the treatment of ulcerative colitis; Pharmaceutical preparations for the treatment of anxiety; Pharmaceutical preparations for the treatment of type 1 diabetes; Pharmaceutical preparations for the treatment of type 2 diabetes; Pharmaceutical preparations for inhibition of tumor necrosis factor (TNF); Pharmaceutical preparations for interacting with nicotine receptors; Pharmaceutical preparations for synthetically simulating non-psychoactive effects of cannabidiol (CBD); Pharmaceutical preparations for liver regeneration; Pharmaceutical preparations for regenerative therapy; Pharmaceutical preparations for acting as an alpha-7nAChR agonist Class 042 Class 042 Computer & Software Services & Scientific Services Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Scientific research for medical purposes in the field of inflammatory diseases; Scientific research for medical purposes in the field of treatment of inflammation; Scientific research for medical purposes in the field of Dupuytren's disease; Scientific research for medical purposes in the field of frozen shoulder; Scientific research for medical purposes in the field of post-operative delirium, post-operative cognitive deficit, and post-operative cognitive decline; Scientific research for medical purposes in the field of non-alcoholic steatohepatitis; Scientific research for medical purposes in the field of fibrosis; Scientific research for medical purposes in the field of liver fibrosis; Scientific research for medical purposes in the field of arthritis; Scientific research for medical purposes in the field of pain treatment ; Scientific research for medical purposes in the field of ulcerative colitis; Scientific research for medical purposes in the field of treatment of anxiety; Scientific research for medical purposes in the field of inhibition of tumor necrosis factor (TNF) and anti-TNF pharmaceuticals; Scientific research for medical purposes in the field of interactions with nicotine receptors; Scientific research for medical purposes in the field of synthetic simulation of non-psychoactive effects of cannabidiol (CBD); Scientific research for medical purposes in the field of synthetic cannabidiol (CBD) analogs; Scientific research for medical purposes in the field of type 1 diabetes; Scientific research for medical purposes in the field of type 2 diabetes; Scientific research for medical purposes in the field of liver regeneration; Scientific research for medical purposes in the field of regenerative therapy; Scientific research for medical purposes in the field of alpha-7nAChR agonists
	180 LIFE SCIENCES & Design 180 Life Sciences Corp. 2202331 4 Aug 2022	ADVERTISED on 7 May 2025	Analgesic preparations; Pharmaceutical preparations for the treatment ... Class 005 Class 005 Pharmaceutical Products Analgesic preparations; Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the treatment of inflammation; Pharmaceutical preparations for the treatment of Dupuytren's disease; Pharmaceutical preparations for the treatment of frozen shoulder; Pharmaceutical preparations for the treatment of post-operative delirium; Pharmaceutical preparations for the treatment of post-operative cognitive deficit; Pharmaceutical preparations for the treatment of post-operative cognitive decline; Pharmaceutical preparations for the treatment of non-alcoholic steatohepatitis; Pharmaceutical preparations for the treatment of fibrosis; Pharmaceutical preparations for the treatment of liver fibrosis; Pharmaceutical preparations for the treatment of arthritis; Pharmaceutical preparations for the treatment of pain; Pharmaceutical preparations for the treatment of ulcerative colitis; Pharmaceutical preparations for the treatment of anxiety; Pharmaceutical preparations for the treatment of type 1 diabetes; Pharmaceutical preparations for the treatment of type 2 diabetes; Pharmaceutical preparations for inhibition of tumor necrosis factor (TNF); Pharmaceutical preparations for interacting with nicotine receptors; Pharmaceutical preparations for synthetically simulating non-psychoactive effects of cannabidiol (CBD); Pharmaceutical preparations for liver regeneration; Pharmaceutical preparations for regenerative therapy; Pharmaceutical preparations for acting as an alpha-7nAChR agonist Class 042 Class 042 Computer & Software Services & Scientific Services Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Scientific research for medical purposes in the field of inflammatory diseases; Scientific research for medical purposes in the field of treatment of inflammation; Scientific research for medical purposes in the field of Dupuytren's disease; Scientific research for medical purposes in the field of frozen shoulder; Scientific research for medical purposes in the field of post-operative delirium, post-operative cognitive deficit, and post-operative cognitive decline; Scientific research for medical purposes in the field of non-alcoholic steatohepatitis; Scientific research for medical purposes in the field of fibrosis; Scientific research for medical purposes in the field of liver fibrosis; Scientific research for medical purposes in the field of arthritis; Scientific research for medical purposes in the field of pain treatment; Scientific research for medical purposes in the field of ulcerative colitis; Scientific research for medical purposes in the field of treatment of anxiety; Scientific research for medical purposes in the field of inhibition of tumor necrosis factor (TNF) and anti-TNF pharmaceuticals; Scientific research for medical purposes in the field of interactions with nicotine receptors; Scientific research for medical purposes in the field of synthetic simulation of non-psychoactive effects of cannabidiol (CBD); Scientific research for medical purposes in the field of synthetic cannabidiol (CBD) analogs; Scientific research for medical purposes in the field of type 1 diabetes; Scientific research for medical purposes in the field of type 2 diabetes; Scientific research for medical purposes in the field of liver regeneration; Scientific research for medical purposes in the field of regenerative therapy; Scientific research for medical purposes in the field of alpha-7nAChR agonists

ADVERTISED

on 7 May 2025

180 LIFE SCIENCES

180 Life Sciences Corp.

2202334 · 4 Aug 2022

005

042

Class 042

Computer & Software Services & Scientific Services

Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Scientific research for medical purposes in the field of inflammatory diseases; Scientific research for medical purposes in the field of treatment of inflammation; Scientific research for medical purposes in the field of Dupuytren's disease; Scientific research for medical purposes in the field of frozen shoulder; Scientific research for medical purposes in the field of post-operative delirium, post-operative cognitive deficit, and post-operative cognitive decline; Scientific research for medical purposes in the field of non-alcoholic steatohepatitis; Scientific research for medical purposes in the field of fibrosis; Scientific research for medical purposes in the field of liver fibrosis; Scientific research for medical purposes in the field of arthritis; Scientific research for medical purposes in the field of pain treatment ; Scientific research for medical purposes in the field of ulcerative colitis; Scientific research for medical purposes in the field of treatment of anxiety; Scientific research for medical purposes in the field of inhibition of tumor necrosis factor (TNF) and anti-TNF pharmaceuticals; Scientific research for medical purposes in the field of interactions with nicotine receptors; Scientific research for medical purposes in the field of synthetic simulation of non-psychoactive effects of cannabidiol (CBD); Scientific research for medical purposes in the field of synthetic cannabidiol (CBD) analogs; Scientific research for medical purposes in the field of type 1 diabetes; Scientific research for medical purposes in the field of type 2 diabetes; Scientific research for medical purposes in the field of liver regeneration; Scientific research for medical purposes in the field of regenerative therapy; Scientific research for medical purposes in the field of alpha-7nAChR agonists

Analgesic preparations; Pharmaceutical preparations for the treatment ...

ADVERTISED

on 7 May 2025

180 LIFE SCIENCES & Design

180 Life Sciences Corp.

2202331 · 4 Aug 2022

005

042

Class 042

Computer & Software Services & Scientific Services

Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Scientific research for medical purposes in the field of inflammatory diseases; Scientific research for medical purposes in the field of treatment of inflammation; Scientific research for medical purposes in the field of Dupuytren's disease; Scientific research for medical purposes in the field of frozen shoulder; Scientific research for medical purposes in the field of post-operative delirium, post-operative cognitive deficit, and post-operative cognitive decline; Scientific research for medical purposes in the field of non-alcoholic steatohepatitis; Scientific research for medical purposes in the field of fibrosis; Scientific research for medical purposes in the field of liver fibrosis; Scientific research for medical purposes in the field of arthritis; Scientific research for medical purposes in the field of pain treatment; Scientific research for medical purposes in the field of ulcerative colitis; Scientific research for medical purposes in the field of treatment of anxiety; Scientific research for medical purposes in the field of inhibition of tumor necrosis factor (TNF) and anti-TNF pharmaceuticals; Scientific research for medical purposes in the field of interactions with nicotine receptors; Scientific research for medical purposes in the field of synthetic simulation of non-psychoactive effects of cannabidiol (CBD); Scientific research for medical purposes in the field of synthetic cannabidiol (CBD) analogs; Scientific research for medical purposes in the field of type 1 diabetes; Scientific research for medical purposes in the field of type 2 diabetes; Scientific research for medical purposes in the field of liver regeneration; Scientific research for medical purposes in the field of regenerative therapy; Scientific research for medical purposes in the field of alpha-7nAChR agonists

Analgesic preparations; Pharmaceutical preparations for the treatment ...

Owners

180 life sciences corp. (2)

Categories

Class 5 (2)

Class 42 (2)

Correspondents

Smart & biggar lp (2)

Display

List View

Grid View

Apply for Trademark

Select countries to protect your logo Trademark

Trademark Name

Country Selected

Canada

C$500/ 1 class + gov fee

United States

C$138/ 1 class + gov fee

Canada

C$500/ 1 class + gov fee

Mexico

C$695/ 1 class + gov fee

European Union

C$975/ 1 class + gov fee

China

C$695/ 1 class + gov fee

South Korea

C$974/ 1 class + gov fee

Japan

C$1,113/ 1 class + gov fee

India

C$347/ 1 class + gov fee

United Kingdom

C$695/ 1 class + gov fee

Australia

C$417/ 1 class + gov fee

Israel

C$974/ 1 class + gov fee

United Arab Emirates

C$974/ 1 class + gov fee

New Zealand

C$974/ 1 class + gov fee

Brazil

C$695/ 1 class + gov fee

Taiwan

C$1,113/ 1 class + gov fee

Ukraine

C$1,113/ 1 class + gov fee

Indonesia

C$974/ 1 class + gov fee

South Africa

C$695/ 1 class + gov fee

Singapore

C$1,113/ 1 class + gov fee

Saudi Arabia

C$1,113/ 1 class + gov fee

Afghanistan

C$1,113/ 1 class + gov fee

Algeria

C$1,113/ 1 class + gov fee

Argentina

C$556/ 1 class + gov fee

Austria

C$1,252/ 1 class + gov fee

Bahrain

C$974/ 1 class + gov fee

Bangladesh

C$834/ 1 class + gov fee

Benelux

C$1,391/ 1 class + gov fee

Bhutan

C$1,252/ 1 class + gov fee

Bolivia

C$1,113/ 1 class + gov fee

Botswana

C$1,809/ 1 class + gov fee

British Virgin Islands

C$1,670/ 1 class + gov fee

Bulgaria

C$1,113/ 1 class + gov fee

Cambodia

C$1,113/ 1 class + gov fee

Chile

C$695/ 1 class + gov fee

Colombia

C$974/ 1 class + gov fee

Congo

C$1,670/ 1 class + gov fee

Costa Rica

C$1,252/ 1 class + gov fee

Croatia

C$1,252/ 1 class + gov fee

Cyprus

C$1,391/ 1 class + gov fee

Czech Republic

C$1,252/ 1 class + gov fee

Denmark

C$1,113/ 1 class + gov fee

Macau

C$974/ 1 class + gov fee

Aruba

C$1,670/ 1 class + gov fee

Greenland

C$1,113/ 1 class + gov fee

Curacao

C$1,670/ 1 class + gov fee

Dominican Republic

C$1,252/ 1 class + gov fee

Ecuador

C$1,113/ 1 class + gov fee

Egypt

C$974/ 1 class + gov fee

El Salvador

C$1,113/ 1 class + gov fee

Ethiopia

C$1,531/ 1 class + gov fee

France

C$1,252/ 1 class + gov fee

Gaza

C$1,113/ 1 class + gov fee

Germany

C$1,252/ 1 class + gov fee

Greece

C$1,113/ 1 class + gov fee

Guatemala

C$1,252/ 1 class + gov fee

Haiti

C$1,252/ 1 class + gov fee

Honduras

C$1,252/ 1 class + gov fee

Hong Kong (SAR)

C$1,252/ 1 class + gov fee

Hungary

C$1,531/ 1 class + gov fee

Iraq

C$2,088/ 1 class + gov fee

Italy

C$1,252/ 1 class + gov fee

Jordan

C$1,113/ 1 class + gov fee

Kazakhstan

C$1,113/ 1 class + gov fee

Kenya

C$1,252/ 1 class + gov fee

Kuwait

C$1,113/ 1 class + gov fee

Laos

C$974/ 1 class + gov fee

Lebanon

C$1,391/ 1 class + gov fee

Lesotho

C$1,670/ 1 class + gov fee

Libya

C$1,252/ 1 class + gov fee

Madrid Protocol (WIPO)

C$2,784/ 1 class + gov fee

Malawi

C$1,531/ 1 class + gov fee

Malaysia

C$974/ 1 class + gov fee

Maldives

C$1,391/ 1 class + gov fee

Morocco

C$1,391/ 1 class + gov fee

Mozambique

C$1,252/ 1 class + gov fee

Myanmar

C$1,113/ 1 class + gov fee

Namibia

C$1,113/ 1 class + gov fee

Nepal

C$974/ 1 class + gov fee

Nicaragua

C$1,252/ 1 class + gov fee

Norway

C$1,252/ 1 class + gov fee

Oman

C$1,531/ 1 class + gov fee

Pakistan

C$1,113/ 1 class + gov fee

Panama

C$1,252/ 1 class + gov fee

Paraguay

C$1,252/ 1 class + gov fee

Peru

C$1,113/ 1 class + gov fee

Philippines

C$1,252/ 1 class + gov fee

Poland

C$695/ 1 class + gov fee

Portugal

C$1,252/ 1 class + gov fee

Puerto Rico

C$1,252/ 1 class + gov fee

Qatar

C$1,113/ 1 class + gov fee

Romania

C$1,252/ 1 class + gov fee

Serbia

C$1,252/ 1 class + gov fee

Slovakia

C$1,252/ 1 class + gov fee

Spain

C$1,252/ 1 class + gov fee

Sri Lanka

C$974/ 1 class + gov fee

Swaziland

C$1,809/ 1 class + gov fee

Sweden

C$1,113/ 1 class + gov fee

Switzerland

C$1,252/ 1 class + gov fee

Thailand

C$1,113/ 1 class + gov fee

Tunisia

C$1,252/ 1 class + gov fee

Turkey

C$1,113/ 1 class + gov fee

Uganda

C$974/ 1 class + gov fee

United Republic of Tanzania

C$974/ 1 class + gov fee

Uruguay

C$1,113/ 1 class + gov fee

Venezuela

C$1,252/ 1 class + gov fee

Vietnam

C$1,113/ 1 class + gov fee

West Bank, Palestine

C$1,113/ 1 class + gov fee

Yemen

C$2,366/ 1 class + gov fee

Albania

C$1,252/ 1 class + gov fee

Andorra

C$1,252/ 1 class + gov fee

Angola

C$1,809/ 1 class + gov fee

Antigua and Barbuda

C$1,670/ 1 class + gov fee

Armenia

C$1,113/ 1 class + gov fee

Azerbaijan

C$1,113/ 1 class + gov fee

Bahamas

C$1,948/ 1 class + gov fee

Barbados

C$1,809/ 1 class + gov fee

Belgium

C$1,391/ 1 class + gov fee

Belize

C$1,809/ 1 class + gov fee

Benin

C$1,113/ 1 class + gov fee

Bosnia and Herzegovina

C$1,391/ 1 class + gov fee

Brunei

C$1,809/ 1 class + gov fee

Burkina Faso

C$1,113/ 1 class + gov fee

Burundi

C$1,670/ 1 class + gov fee

Cabo Verde

C$1,252/ 1 class + gov fee

Cameroon

C$1,113/ 1 class + gov fee

Central African Republic (CAR)

C$1,113/ 1 class + gov fee

Chad

C$1,113/ 1 class + gov fee

Comoros

C$1,113/ 1 class + gov fee

Cote d'Ivoire

C$1,113/ 1 class + gov fee

Czechia

C$1,391/ 1 class + gov fee

Djibouti

C$1,670/ 1 class + gov fee

Dominica

C$1,809/ 1 class + gov fee

Equatorial Guinea

C$1,113/ 1 class + gov fee

Eritrea

C$1,391/ 1 class + gov fee

Estonia

C$1,809/ 1 class + gov fee

Eswatini

C$1,809/ 1 class + gov fee

Fiji

C$1,252/ 1 class + gov fee

Finland

C$974/ 1 class + gov fee

Gabon

C$1,113/ 1 class + gov fee

Gambia

C$1,252/ 1 class + gov fee

Georgia

C$1,113/ 1 class + gov fee

Ghana

C$1,391/ 1 class + gov fee

Grenada

C$1,809/ 1 class + gov fee

Guinea

C$1,113/ 1 class + gov fee

Guinea-Bissau

C$1,113/ 1 class + gov fee

Guyana

C$1,809/ 1 class + gov fee

Iceland

C$1,809/ 1 class + gov fee

Ireland

C$1,113/ 1 class + gov fee

Jamaica

C$1,670/ 1 class + gov fee

Kiribati

C$1,391/ 1 class + gov fee

Kosovo

C$1,252/ 1 class + gov fee

Kyrgyzstan

C$1,252/ 1 class + gov fee

Latvia

C$974/ 1 class + gov fee

Liberia

C$1,391/ 1 class + gov fee

Liechtenstein

C$1,391/ 1 class + gov fee

Lithuania

C$974/ 1 class + gov fee

Luxembourg

C$1,391/ 1 class + gov fee

Madagascar

C$1,391/ 1 class + gov fee

Mali

C$1,113/ 1 class + gov fee

Malta

C$834/ 1 class + gov fee

Marshall Islands

C$1,391/ 1 class + gov fee

Mauritania

C$1,113/ 1 class + gov fee

Mauritius

C$1,391/ 1 class + gov fee

Micronesia

C$1,391/ 1 class + gov fee

Moldova

C$1,391/ 1 class + gov fee

Monaco

C$1,948/ 1 class + gov fee

Mongolia

C$834/ 1 class + gov fee

Montenegro

C$1,252/ 1 class + gov fee

Nauru

C$1,391/ 1 class + gov fee

Netherlands

C$1,391/ 1 class + gov fee

Niger

C$1,113/ 1 class + gov fee

Nigeria

C$556/ 1 class + gov fee

North Macedonia

C$1,252/ 1 class + gov fee

Palau

C$1,391/ 1 class + gov fee

Palestine

C$1,391/ 1 class + gov fee

Papua New Guinea

C$1,113/ 1 class + gov fee

Rwanda

C$1,391/ 1 class + gov fee

Saint Kitts and Nevis

C$1,809/ 1 class + gov fee

Saint Lucia

C$1,809/ 1 class + gov fee

Saint Vincent and the Grenadines

C$1,809/ 1 class + gov fee

Samoa

C$1,670/ 1 class + gov fee

San Marino

C$1,391/ 1 class + gov fee

Sao Tome and Principe

C$1,391/ 1 class + gov fee

Senegal

C$1,113/ 1 class + gov fee

Seychelles

C$1,391/ 1 class + gov fee

Sierra Leone

C$1,391/ 1 class + gov fee

Slovenia

C$1,252/ 1 class + gov fee

Solomon Islands

C$1,391/ 1 class + gov fee

Somalia

C$1,391/ 1 class + gov fee

South Sudan

C$1,391/ 1 class + gov fee

Suriname

C$2,227/ 1 class + gov fee

Tajikistan

C$1,113/ 1 class + gov fee

Tanzania

C$974/ 1 class + gov fee

Timor-Leste

C$1,391/ 1 class + gov fee

Togo

C$1,113/ 1 class + gov fee

Tonga

C$1,809/ 1 class + gov fee

Trinidad and Tobago

C$1,670/ 1 class + gov fee

Turkmenistan

C$1,113/ 1 class + gov fee

Tuvalu

C$1,391/ 1 class + gov fee

Uzbekistan

C$974/ 1 class + gov fee

Vanuatu

C$1,670/ 1 class + gov fee

Zambia

C$1,252/ 1 class + gov fee

Zimbabwe

C$1,252/ 1 class + gov fee

OAPI

C$1,252/ 1 class + gov fee

ARIPO

C$1,391/ 1 class + gov fee

End of search results

Page 1 of 1